# GSK2190915 Pediatric Study

> **NCT01286844** · PHASE2 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** GSK2190915A 5mg
- **DRUG:** GSK2190915A 10mg
- **DRUG:** GSK2190915A 25mg
- **DRUG:** GSK2190915A 50mg
- **DRUG:** GSK2190915A 100mg

## Key facts

- **NCT ID:** NCT01286844
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-11
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01286844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01286844, "GSK2190915 Pediatric Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01286844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*